Summary
HCA Healthcare, Inc. reported solid financial performance for the first quarter of 2025, with revenues increasing by 5.7% year-over-year to $18.321 billion. This growth was driven by a combination of increased equivalent admissions and higher revenue per equivalent admission. Net income attributable to HCA Healthcare, Inc. reached $1.610 billion, or $6.45 per diluted share. While revenue and net income showed positive growth, the company experienced a significant decline in cash flow from operating activities, down $818 million to $1.651 billion, primarily due to negative changes in working capital. The company continues to execute its capital allocation strategy, with substantial share repurchases in the quarter. Management expressed confidence in its ability to meet liquidity needs through operating cash flows, available credit facilities, and access to debt markets, despite a significant debt load of $44.576 billion at the end of the quarter. The report also highlights ongoing risk factors, including inflationary pressures, regulatory changes in healthcare, and the management of substantial indebtedness.
Financial Highlights
46 data points| Revenue | $18.32B |
| Operating Expenses | $15.99B |
| Interest Expense | $547.00M |
| Net Income | $1.61B |
| EPS (Basic) | $6.52 |
| EPS (Diluted) | $6.45 |
| Shares Outstanding (Basic) | 246.94M |
| Shares Outstanding (Diluted) | 249.44M |
Key Highlights
- 1Revenue increased 5.7% to $18.321 billion in Q1 2025, driven by higher equivalent admissions and revenue per equivalent admission.
- 2Net income attributable to HCA Healthcare, Inc. was $1.610 billion, or $6.45 per diluted share, a slight increase from the prior year.
- 3Cash flow from operating activities decreased by $818 million to $1.651 billion, largely due to unfavorable working capital movements.
- 4The company repurchased approximately $2.506 billion of its common stock in the first quarter of 2025.
- 5Total debt stood at $44.576 billion as of March 31, 2025, with a strong availability of $7.766 billion under its senior unsecured credit facility.
- 6Consolidated inpatient surgeries saw a marginal increase of 0.3%, while outpatient surgeries declined by 2.5% on a consolidated basis.
- 7The company anticipates capital expenditures between $5.0 billion and $5.2 billion for the full year 2025.